TrainFES
TrainFES is a Chilean digital neuro-rehabilitation platform that delivers FDA-certified Functional Electrical Stimulation therapy through an AI-assisted cloud platform, serving paralysis patients with stroke, spinal cord injury, traumatic brain injury, and cerebral palsy across its own clinic, partner clinic network, and Teletón Chile institutes.
- Company typePrivate
- Founded2019
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What TrainFES does
TrainFES is a Chile-headquartered digital neuro-rehabilitation company that delivers evidence-based therapy for patients with paralysis caused by stroke (ACV), spinal cord injury (LME), traumatic brain injury (TEC), cerebral palsy (PC), and other neurological conditions. The company was founded in 2013 and has built its current telerehabilitation platform around "Método TRAINFES," a four-pillar methodology combining FDA-certified Functional Electrical Stimulation (FES) medical devices, an AI-assisted cloud platform, daily therapy programs usable in both clinic and home settings, and continuous specialist accompaniment. TrainFES's technology is certified by the US FDA, scientifically validated through peer-reviewed publications, and manufactured under ISO 13485:2016 quality standards.
The core product stack comprises the FES medical devices themselves (hardware that promotes motor re-learning and neuroplasticity), the AI-powered cloud platform that personalizes and auto-programs device parameters from a patient's phone, and the "TRAINFES Method" service delivery framework. Distribution runs through three channels: the proprietary TRAINFES CENTER innovation and rehabilitation facility in Santiago; the TRAINFES NETWORK of accredited partner clinics; and direct-to-patient inquiry via website contact forms and WhatsApp. A flagship institutional partnership with Teletón Chile has extended TrainFES's telerehabilitation platform across 14 Teletón institutes nationally.
TrainFES generates revenue from subscription-based rehabilitation programs delivered at TRAINFES CENTER and through the accredited clinic network, as well as from the sale or licensing of FDA-certified FES medical devices and cloud platform access to partner clinics and institutions. The company employs 11–50 people, has rehabilitated more than 3,000 patients since 2019, and raised a $1.4 million seed round in July 2022 led by Amarena and Invexor to support entry into the US market and continued technology development.
TrainFES firmographics
Firmographics- Name
- TrainFES
- Legal name
- TrainFES
- Website
- https://trainfes.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- TrainFES is a Chilean digital neuro-rehabilitation platform that delivers FDA-certified Functional Electrical Stimulation therapy through an AI-assisted cloud platform, serving paralysis patients with stroke, spinal cord injury, traumatic brain injury, and cerebral palsy across its own clinic, partner clinic network, and Teletón Chile institutes.
- Ownership category
- akta.pro rank
Where TrainFES is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
TrainFES business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Rehabilitation Programs: TrainFES generates revenue through rehabilitation programs delivered at its TRAINFES CENTER and through its TRAINFES NETWORK of accredited clinics, which feature the company's proprietary technology and methodology.
- Medical Devices and Technology Licensing: Sale or licensing of FDA-certified FES medical devices and cloud platform access to partner clinics and institutions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Rehabilitation programs at TRAINFES CENTER or via TRAINFES NETWORK |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
TrainFES product offering
Product offeringCore offering
TrainFES provides a digital neurological rehabilitation platform that combines FDA-certified Functional Electrical Stimulation (FES) medical devices with an AI-assisted cloud platform. The "Método TRAINFES" is a four-pillar rehabilitation methodology (medical technology, AI cloud platform, daily therapy programs for clinic and home use, and continuous specialist accompaniment) delivered through the company's own TRAINFES CENTER and its TRAINFES NETWORK of accredited clinics, targeting patients with paralysis caused by stroke, spinal cord injury, traumatic brain injury, and cerebral palsy.
Product overview
TrainFES offers a unified telerehabilitation platform built around the "Método TRAINFES" (TRAINFES Method), a cloud-based neurological rehabilitation solution. The core offering combines AI-assisted therapy programming with medical devices for functional electrical stimulation. Patients access the system through TRAINFES CENTER (the company's own rehabilitation center) or via the TRAINFES NETWORK of accredited partner clinics. The platform delivers personalized, daily rehabilitation therapy for neurological conditions including stroke, spinal cord injury, traumatic brain injury, and cerebral palsy, enabling patients to continue therapy at home after initial clinic-based training.
Differentiator
Problem solved
Functional benefit
Brands
- TRAINFES CENTER: Company's innovation and rehabilitation center located in Santiago, Chile.
- TRAINFES NETWORK
Products and services
- Método TRAINFES (TRAINFES Method) A four-pillar evidence-based neurological rehabilitation method that uses FES medical devices, an AI-assisted cloud platform, daily therapy programs usable in both clinic and home settings, and ongoing specialist accompaniment to treat patients with paralysis from stroke, spinal cord injury, traumatic brain injury, and cerebral palsy.
- TRAINFES CENTER TrainFES's owned innovation and rehabilitation center in Santiago, Chile, offering patients direct access to TrainFES rehabilitation programs using the company's proprietary FES technology and Método TRAINFES.
- TRAINFES NETWORK A network of accredited partner clinics equipped with TrainFES technology and trained in the Método TRAINFES, enabling patients to access TrainFES rehabilitation programs through certified third-party providers.
Quantifiable outcome
- Over 3,000 patients rehabilitated since 2019
- +2 more outcomes
Companies that use TrainFES
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
TrainFES technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
TrainFES partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Teleton ChilecoreTeleton Chile partnered with TrainFES to deploy the telerehabilitation platform across 14 Teleton institutes in Chile. Dr. Bruno Camaggi, Director Médico Nacional Teletón, endorsed TrainFES as a 'virtual co-therapist' that breaks the paradigm of neurological therapy needing a physical gym.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
TrainFES competitors and assessment
Company assessmentDirect peers
- Myomo: Myomo produces myoelectric orthoses for upper-limb paralysis following stroke or brachial plexus injury, sold through clinics and direct-to-patient channels. It is comparable to TrainFES as a neuro-rehab medical device company serving similar patient populations.
- Bioness: Bioness is a US-based medical device company specializing in functional electrical stimulation (FES) and neuro-rehabilitation devices for stroke, spinal cord injury, and foot drop. It is the most direct FES-device competitor to TrainFES, with FDA-cleared products distributed through hospitals and rehabilitation clinics in North America.
- Saebo: Saebo manufactures upper-limb orthoses and FES-based rehabilitation devices for stroke and neurological injury patients, sold directly to clinicians and patients globally. Its product mix for neurological rehab overlaps directly with TrainFES's FES-plus-software approach.
- Restorative Therapies: Restorative Therapies (now owned by Roper Technologies) provides FES cycling and therapy systems for individuals with spinal cord injury, stroke, and other neurological conditions. It is a direct peer in the FES-based rehabilitation equipment market.
- Neofect: Neofect delivers smart rehabilitation devices and software (e.g., Rapha, NeoMano, Visio) for stroke and neurological recovery across clinical and home settings. It is comparable to TrainFES as a neuro-rehab platform combining hardware, software, and remote therapy delivery.
- Hocoma: Hocoma (a DIH Medical company) develops robotic and sensor-based neuro-rehabilitation devices used in clinics worldwide for gait and upper-limb therapy after stroke and spinal cord injury. It competes with TrainFES in the technology-enabled neuro-rehab category serving hospitals and rehab centers.
Emerging players
- MindMaze: MindMaze builds digital neuro-rehabilitation platforms combining gamified therapy, AI, and hardware for stroke and brain injury recovery. It overlaps with TrainFES on the AI-cloud-delivered neuro-rehab angle, though MindMaze is more software-led.
- Flint Rehab: Flint Rehab (Flosom) makes accessible neurorehabilitation devices like MusicGlove and FitMi for stroke and hand-impairment therapy. It is comparable to TrainFES in the home-based neuro-rehab device space with a digital/connected therapy approach.
Broad incumbents
- Ekso Bionics: Ekso Bionics develops exoskeleton and robotic rehabilitation devices for stroke, spinal cord injury, and acquired brain injury. It is a publicly traded neuro-rehab device maker with broader product breadth but overlapping clinical indications.
- ReWalk Robotics: ReWalk Robotics develops wearable robotic exoskeletons for individuals with spinal cord injury and stroke rehabilitation. It is comparable to TrainFES as a neuro-rehab device maker targeting SCI and stroke populations, though with a different product modality (powered exoskeleton vs FES).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
TrainFES social profiles
Digital presenceTrainFES compliance and trust
Trust signalCompliance2 records
TrainFES financial estimates
Financial estimateRevenue estimate
Valuation estimate
TrainFES leadership team
Management profileNumber of profiles
Profiles1 record
TrainFES funding detail
Funding detailFunding overview
Funding rounds7 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TrainFES M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TrainFES
What does TrainFES do?
TrainFES provides a digital neurological rehabilitation platform that combines FDA-certified Functional Electrical Stimulation (FES) medical devices with an AI-assisted cloud platform. The "Método TRAINFES" is a four-pillar rehabilitation methodology (medical technology, AI cloud platform, daily therapy programs for clinic and home use, and continuous specialist accompaniment) delivered through the company's own TRAINFES CENTER and its TRAINFES NETWORK of accredited clinics, targeting patients with paralysis caused by stroke, spinal cord injury, traumatic brain injury, and cerebral palsy.
Is TrainFES a public or private company?
TrainFES is a private company. It is classified as venture growth investor backed and is currently operating.
When was TrainFES founded?
TrainFES was founded in 2019. It employs 11 to 50 people.
Where is TrainFES based?
TrainFES is headquartered in San Francisco, United States, in the North America region.
How does TrainFES make money?
Two revenue lines are on record. Rehabilitation Programs are the primary driver. The others are medical Devices and Technology Licensing.
Who are TrainFES's main competitors?
Direct peers on record are Myomo, Bioness, Saebo, Restorative Therapies, Neofect and Hocoma. Emerging players are MindMaze and Flint Rehab. Broad incumbents are Ekso Bionics and ReWalk Robotics.
Does TrainFES have an API?
No public API is recorded for TrainFES.